GSK Looks To Immuno-Neurology In $700m Alector Tie-up

Return to neuroscience follows activist investor showdown

 
• By Joseph Haas
  
business
GSK and Alector come together in major neuroscience collaboration
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business